Kerr Drug holds grand opening of second community care center
RALEIGH, N.C. Kerr Drug, the pharmacy chain “pioneering community pharmacy care” in 102 retail locations throughout The Carolinas, announces the opening of its second community health care center at 1050 South Horner Blvd in Sanford, N.C. The grand opening will take place today, beginning at 9 a.m.
“We made a conscious decision—a commitment—to provide North Carolinians with a comprehensive health care facility focused on their overall health,” said Anthony Civello, president and chief executive officer of Kerr Drug. ”To have developed this commitment into a new industry and life-changing center is a wonderful accomplishment for the entire Kerr Drug family.”
An industry-unique facility focused extensively on the complete health of its patients, the new center is set to revolutionize the way residents of North Carolina receive pharmacy and healthcare services. This new prototype combines the community health care center with a large, fully merchandised retail drug store and a Seattle’s Best cafe, offering beverages and foods in a relaxing environment.
The center will also offer expanded clinical pharmacy services, and provide a variety of private one-on-one patient services, intervention and education performed by health professionals, such as a physician’s assistant, clinical pharmacists, weight loss/nutritionists specialists and respiratory therapists.
Areas throughout the new center will be devoted to cardiac and lung health, women’s care, advanced skin and foot care, breast-feeding support and other specialty departments. A complete line of health screenings will be also available, including cholesterol, bone density, artery disease, glucose, respiratory and blood pressure.
For patients with otherwise limited access to these services, the new center represents a convenient and cost-effective way to receive professional preventative health care. It will also be equipped with a state-of-the-art “Healthy Living” durable medical equipment section for patients needing walkers, hospital beds, mobility and safety equipment, and home health care items.
“This center will set the standard for pharmacy care and will positively impact the health care landscape in North Carolina and the entire country,” said Civello.
Celgene to acquire Pharmion for $72/share
SUMMIT, N.J. Celgene and Pharmion have announced a merger agreement, under which Celgene has agreed to acquire Pharmion. Celgene will acquire all of Pharmion’s outstanding shares of common stock for $72 per share payable in cash and share of Celgene common stock.
Under the agreement, Celgene will acquire the rights to three popular Pharmion oncology drugs: Revlimid, Thalomid, and Vidaza. Thalmoid and Revlimid are used to treat patients with multiple myeloma. Vidaza is used to treat myelodysplastic syndromes.
“The acquisition of Pharmion is an exceptional strategic fit that will expand our role as a leader in hematology and oncology,” said Sol Barer, chairman and chief executive officer of Celgene Corporation. “Our combined global infrastructure will leverage the therapeutic and commercial potential of Pharmion’s products, particularly Vidaza, which has the potential to become a major global therapy. By bringing together the talents and resources of both companies, we move closer to our vision of becoming a leading hematology and oncology company in the world, expanding our industry leading programs for safety, access and patient support.”
RxHub introduces Rx 4 Success e-prescribing program
ST. PAUL, Minn. RxHub, a company that keeps track of patient-specific medication history and pharmacy benefit information, has announced a new product for e-prescribing, the Rx 4 Success.
The new program was developed to target four main areas of e-prescribing: utilization of Centers for Medicaid and Medicare Services approved ePrescribing transactions including eligibility, formulary and benefits, and medication history. The program will also integrate true electronic delivery of prescriptions to retail and mail order pharmacies. It will also keep consistent rules-based applications of clinical decision support content and formulate transactional data to support the development of outcomes based on pay-for-performance programs.
“We are extremely proud to be associated with our growing roster of partners which includes many of the healthcare industry’s foremost technology innovators,” stated Doug Johnson, vice president of business development for technology partners at RxHub. “Their collective vision not only helped shape Rx 4 Success but provides the foundation for ongoing market driven performance analysis and improvement.”
Rx 4 Success will become a participation requirement for technology partners connected to the RxHub network as of July 31, 2008.